Vrijmoeth P, Heijtink R A, Schreuder H, Kroes A C
Erasmus Universiteit, afd. Virologie, Rotterdam.
Ned Tijdschr Geneeskd. 1997 Aug 30;141(35):1694-7.
To determine whether vaccination against hepatitis B may be omitted in persons with isolated positive anti-HBc.
Prospective study using control groups. SETTING'S: Heeren Loo-Lozenoord, Ermelo, the Netherlands.
Twenty-six older residents (group P) with isolated anti-HBc positivity (HBsAg negative and anti-HBs < 10 IU/l) were given hepatitis B vaccine (3 doses); 16 matched controls (group C1) lacking hepatitis B markers, received a primary vaccination (3 doses), 8 controls (group C2) with a immune status based on infection in the past received vaccination (3 doses) and 27 controls (group C3) were given a booster vaccination (1 dose) after vaccination 7 years earlier. The anti-HBs response was measured 0, 1 and 7 months after the first vaccine dose. An anamnestic response was defined as a fourfold rise of anti-HBs after one dose of vaccine or--in the absence of an anti-HBs titer in the prevaccination serum--a response > or = 10 IU/l after one dose of vaccine. A primary response was defined as an anti-HBs response > or = 10 IU/l after giving 3 vaccines, while the criteria for an anamnestic response were not met.
In the isolated anti-HBc group (P) and in the corresponding control group (C2) 15 and 12.5%, respectively, showed an anamnestic response; the majority reacted with a primary response or did not respond at all. The subjects given a primary vaccination (C1) responded in 62.5% with a primary response while those vaccinated earlier (C3) responded in 92.6% with a fourfold rise of anti-HBs.
The anti-HBs response to vaccination in older mentally handicapped persons is delayed and there is a reduced chance of development of a protective anti-HBs titer. The majority of individuals with isolated anti-HBc showed a primary response. In these persons vaccination should not be omitted, especially if there is a risk of hepatitis B.
确定对于单纯抗-HBc阳性者是否可省略乙肝疫苗接种。
采用对照组的前瞻性研究。地点:荷兰黑伦洛-洛泽诺德、埃尔默洛。
26名单纯抗-HBc阳性的老年居民(P组)(HBsAg阴性且抗-HBs<10 IU/l)接种乙肝疫苗(3剂);16名匹配的无乙肝标志物的对照者(C1组)接受初次接种(3剂),8名既往有感染所致免疫状态的对照者(C2组)接种疫苗(3剂),27名对照者(C3组)在7年前接种疫苗后接受加强接种(1剂)。在首剂疫苗接种后0、1和7个月测量抗-HBs反应。回忆反应定义为一剂疫苗接种后抗-HBs升高四倍,或者在接种前血清中无抗-HBs滴度时,一剂疫苗接种后反应≥10 IU/l。初次反应定义为接种3剂疫苗后抗-HBs反应≥10 IU/l,而未达到回忆反应标准。
在单纯抗-HBc组(P组)和相应对照组(C2组)中,分别有15%和12.5%表现出回忆反应;大多数人表现为初次反应或根本无反应。接受初次接种的受试者(C1组)有62.5%表现出初次反应,而早期接种疫苗的受试者(C3组)有92.6%表现出抗-HBs升高四倍。
老年智障者接种疫苗后的抗-HBs反应延迟,产生保护性抗-HBs滴度的机会减少。大多数单纯抗-HBc阳性个体表现出初次反应。在这些人群中不应省略疫苗接种,尤其是存在乙肝感染风险时。